Please login to the form below

Not currently logged in
Email:
Password:

Lonza to buy Arch Chemicals for $1.4bn

Life science industry suppliers, Lonza, are to acquire outstanding shares of biocides company Arch Chemicals for $47.20 per share – around $1.4bn in total

Life science industry suppliers, Lonza, are to acquire outstanding shares of biocides company Arch Chemicals for $47.20 per share – around $1.4bn in total.

A tender offer has been agreed between the two companies, subject to conditions including clearance from antitrust regulatory authorities.

Switzerland-based Lonza said it expects to commence the tender offer by July 15, 2011 and to complete the tender offer later in 2011.

According to the company, once the transaction is complete, Lonza will have the world's leading microbial control business, with related products being used in such areas as water treatment, hygiene and materials protection.

The micriobial market is estimated to have a global value of around $10bn, and a growth rate of four to six per cent every year.

Stefan Borgas, CEO of Lonza, said: "Lonza and Arch Chemicals offer highly complementary products and technologies and together will be the global leader in controlling unwanted microbes. The business will enjoy a strong platform for accelerated future growth for the benefit of all our stakeholders."

12th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics